View in EDS HTML Full Text PDF Full Text

A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.

Saved in:
Bibliographic Details
Title: A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.
Authors: Wang, Yuanyuan1,2,3 (AUTHOR), Guo, Haoyue1,2,3 (AUTHOR), Han, Ruoshuang3,4 (AUTHOR), Wu, Yuhan3,5 (AUTHOR), He, Taiping1,2,3 (AUTHOR), Diao, Meng1,2,3 (AUTHOR), Xiong, Anwen1,2,3 (AUTHOR), Zhou, Fei1,2,3 (AUTHOR), Cheng, Lei6 (AUTHOR), Zhao, Chao6 (AUTHOR), Li, Xuefei6 (AUTHOR), Zhou, Caicun1,2,3 (AUTHOR) doctorcaicunzhou@163.com
Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 191154588
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Yuanyuan%22">Wang, Yuanyuan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Haoyue%22">Guo, Haoyue</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+Ruoshuang%22">Han, Ruoshuang</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Yuhan%22">Wu, Yuhan</searchLink><relatesTo>3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Taiping%22">He, Taiping</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Diao%2C+Meng%22">Diao, Meng</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xiong%2C+Anwen%22">Xiong, Anwen</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Fei%22">Zhou, Fei</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Lei%22">Cheng, Lei</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Chao%22">Zhao, Chao</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xuefei%22">Li, Xuefei</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Caicun%22">Zhou, Caicun</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> doctorcaicunzhou@163.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cellular+Oncology+%282211-3428%29%22">Cellular Oncology (2211-3428)</searchLink>. Feb2026, Vol. 49 Issue 1, p1-13. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=191154588
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13402-025-01152-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1
    Titles:
      – TitleFull: A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Yuanyuan
      – PersonEntity:
          Name:
            NameFull: Guo, Haoyue
      – PersonEntity:
          Name:
            NameFull: Han, Ruoshuang
      – PersonEntity:
          Name:
            NameFull: Wu, Yuhan
      – PersonEntity:
          Name:
            NameFull: He, Taiping
      – PersonEntity:
          Name:
            NameFull: Diao, Meng
      – PersonEntity:
          Name:
            NameFull: Xiong, Anwen
      – PersonEntity:
          Name:
            NameFull: Zhou, Fei
      – PersonEntity:
          Name:
            NameFull: Cheng, Lei
      – PersonEntity:
          Name:
            NameFull: Zhao, Chao
      – PersonEntity:
          Name:
            NameFull: Li, Xuefei
      – PersonEntity:
          Name:
            NameFull: Zhou, Caicun
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 22113428
          Numbering:
            – Type: volume
              Value: 49
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cellular Oncology (2211-3428)
              Type: main
ResultId 1